0001126234-21-000113.txt : 20210813
0001126234-21-000113.hdr.sgml : 20210813
20210813163242
ACCESSION NUMBER: 0001126234-21-000113
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210811
FILED AS OF DATE: 20210813
DATE AS OF CHANGE: 20210813
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schuchart Aaron
CENTRAL INDEX KEY: 0001709258
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35342
FILM NUMBER: 211172700
MAIL ADDRESS:
STREET 1: C/O AEGLEA BIOTHERAPEUTICS, INC.
STREET 2: 901 S.MOPAC EXPWY,BARTONOAKSPLAZONE,#250
CITY: AUSTIN
STATE: TX
ZIP: 78746
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LUMOS PHARMA, INC.
CENTRAL INDEX KEY: 0001126234
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 421491350
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4200 MARATHON BLVD.
STREET 2: SUITE 200
CITY: AUSTIN
STATE: TX
ZIP: 78756
BUSINESS PHONE: 512-215-2630
MAIL ADDRESS:
STREET 1: 4200 MARATHON BLVD.
STREET 2: SUITE 200
CITY: AUSTIN
STATE: TX
ZIP: 78756
FORMER COMPANY:
FORMER CONFORMED NAME: NEWLINK GENETICS CORP
DATE OF NAME CHANGE: 20001012
4
1
wf-form4_162888671669667.xml
FORM 4
X0306
4
2021-08-11
0
0001126234
LUMOS PHARMA, INC.
(LUMO)
0001709258
Schuchart Aaron
4200 MARATHON BLVD
SUITE 200
AUSTIN
TX
78756
0
1
0
0
Chief Business Officer
Common Stock
2021-08-11
4
P
0
300
7.35
A
1337
D
Common Stock
2021-08-12
4
P
0
1700
7.42
A
3037
D
Includes 695 restricted stock units ("RSUs") previously reported as holdings of the Reporting Person granted under the Issuer's 2009 Equity Incentive Plan (the "Plan"). The RSUs will vest, and shares will be delivered to the Reporting Person in a series of four successive annual installments with the next installment occurring on February 1, 2022, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
Includes 109 shares acquired under the Lumos Pharma, Inc. 2010 Employee Stock Purchase Plan on June 30, 2021.
/s/ Ryan Trytten, attorney-in-fact
2021-08-13